Universal Health Services (UHS) PT Raised to $271 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Universal Health Services (UHS) PT Raised to $227 at Cantor Fitzgerald
October 28, 2024 6:38 AM EDTCantor Fitzgerald analyst Sarah James raised the price target on Universal Health Services (NYSE: UHS) to $227.00 (from $219.00) while maintaining a Neutral rating.
The analyst comments "We are raising our 12-month price target to $227 from $219. Our 7.9x '26E EV/EBITDA reflects... More
Universal Health Services (UHS) PT Lowered to $211 at RBC Capital
October 28, 2024 6:31 AM EDTRBC Capital analyst Frank Morgan lowered the price target on Universal Health Services (NYSE: UHS) to $211.00 (from $222.00) while maintaining a Sector Perform rating.
The analyst comments "UHS stock traded off ~10% Friday on elevated buyside expectations with several investors pointing to softer... More
Deutsche Bank Reiterates Buy Rating on Universal Health Services (UHS)
October 28, 2024 5:56 AM EDTDeutsche Bank analyst Pito Chickering reiterated a Buy rating and $240.00 price target on Universal Health Services (NYSE: UHS)
The analyst comments "Net-net. While the election may be an overhang over the next couple of weeks, especially given Trumps position on exchange subsidies; ultimately, we dont believe UHS deserves to be down almost 10% today. The 3Q performance and lack of an increase to guidance wasnt enough to support the stock... More
